Researchers at IRB Barcelona unravel a role for tumour suppressor genes in restricting the growth of neighbouring cell populations.
The study, published yesterday in PLoS Biology, might have implications for understanding the early events of tumorigenesis and the selection of the tumour-initiating cells.
The newspaper “El Periódico de Catalunya” has echoed the award ceremony of the 77 grants given by the “Obra Social La Caixa” foundation to support doctoral students. This grant programme aims to retain Spanish students and attract international students with talent for research, both for Spanish universities and Severo Ochoa centres. In this edition, IRB Barcelona students Jürgen Walther, Craig Donoghue, Elzbieta Szulc, and Lada Murcia received these awards.
“El País” newspaper has published an article on the Barcelona BioMed Conference “Drosophila as a model in cancer”. It includes statements made by Marco Milán, ICREA researcher and head of the Development and Growth Control Laboratory, and Cayetano González, ICREA researcher and head of the Cell Division Laboratory, both at IRB Barcelona and co-organizers of this scientific meeting, which is supported by the BBVA Foundation.
The article highlights the project presented by Ross Cagan, director of the Center for Personalized Cancer Therapeutics at Mount Sinai Hospital (United States), which uses flies that have the same tumours as those found in human patients to design personalized...
Various media have echoed the news about the Barcelona BioMed Conference on the use of the fly Drosophila melanogaster as a model to study cancer. Organised by IRB Barcelona with the support of the BBVA Foundation, the meeting will take place from 15 to 17 June in Barcelona. Marco Milán, ICREA researcher and head of the Development and Growth Control Laboratory, and Cayetano González, ICREA researcher and head of the Cell Division Laboratory, both at IRB Barcelona, have selected the 23 speakers who will participate in the conference.
In the conference “Drosophila as a model in cancer”, to be held from 15 to 17 June in Barcelona, IRB Barcelona and the BBVA Foundation bring together a select group of leading scientists that use the fruit fly for cancer research.
This fly can be used to study specific types of tumour, ranging from leukaemia to brain tumours, and complex processes such as metastasis or the wasting syndrome (extreme muscle weakness) associated with cancer. In addition, Drosophila has proved to be an excellent tool for drug screening in vivo.
Nobert Perrimon is among the invited speakers. From his lab at Harvard, he has performed one of the largest screenings of molecules in flies in search of new anti-tumour applications of drugs that have already been approved by the FDA.
Special mention is also given to the participation of Sam Jackson, from the National Center for the Replacement, Refinement and Reduction of Animals in Research, a British organisation that promotes and supports the use of invertebrate models, such as Drosophila, for cancer research.
The two-day workshop is part of the Teachers and Science programme, organised by the Catalunya-La Pedrera Foundation. This year’s programme will involve the participation of nine research centres from around Catalonia
The overall objective is to improve science teaching in order to increase scientific vocation among students
The IRB Barcelona workshop is dedicated to biomedical research with fruit flies
This year IRB Barcelona has supervised 39 research projects done by secondary school students
The awardees will present their work in two public science fairs to be held this year
Diario Médico echoes on an article about nutrition developed by Lara Barrio and Marco Milán in the Development and Growth Control laboratory. The work was published in Cell Reports.
Scientists at IRB Barcelona have observed that, when deprived of food, flies that do not express p53 show poor management of energy store.
The study, published today in Cell Reports, further supports the involvement of this molecule—traditionally associated with tumour suppression—in metabolism.
The researchers provide new insights to study p53 function in metabolic diseases such as diabetes and obesity.
The "Diario Médico" reports on statements by Marco Milán on the uses of Drosophila melanogaster to study diseases such as cancer and autoimmune conditions. Milán coorganised the European Drosophila Research Congress, which was held in Barcelona from 16 to 19 October.
Read the news in "Diario Médico" (PDF in Spanish)